Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 35

Nubank files for dual listing

The Tencent and Berkshire Hathaway-backed digital bank is seeking to grow its valuation from $30bn in June to over $50m in flotations in the US and Brazil.

Nov 3, 2021

Fluence fattens IPO to $998m

AES and Siemens are each retaining nearly 35% of the energy storage system provider, which has closed an upsized initial public offering.

Nov 3, 2021

Terran takes off with $1.58bn reverse merger

The Lockheed Martin-backed satellite manufacturer is teaming up with Tailwind Two Acquisition Corp to list on the New York Stock Exchange.

Nov 2, 2021

Delhivery to ship in $998m through IPO

The FedEx and SoftBank-backed shipping service provider’s offering, set to take place early next year, will reportedly value it between $5.5bn and $6bn.

Nov 2, 2021

Generac Holdings to buy Ecobee

The Amazon, Carrier, AGL Energy and Just Energy-backed smart thermostat producer is set to be taken over by Generac Holdings in a deal that could reach $770m.

Nov 2, 2021

Agendia scans for Nasdaq IPO

Norgine, Axa and Debiopharm are in line for exits as the breast cancer diagnostics test provider is aiming to go public to boost research and development and commercial activities.

Nov 2, 2021

Daily Deal Round Up: November 1, 2021

Cell therapy developer Hopstem completed a $40m Eli Lilly-backed series B round while cybersecurity technology developer SlashNext secured $26m from investors including Telia and Ayala Group.

Nov 1, 2021

PB Fintech lists in $750m IPO

The Info Edge, Intel, Tencent and SoftBank-backed operator of insurance and financial products comparison tools PolicyBazaar and PaisaBazaar has gone public, having raised $343m in pre-IPO funding.

Nov 1, 2021

Udemy completes route to IPO

The Prosus and Benesse-backed online skills learning marketplace priced its shares at the top of their range to raise approximately $421m.

Nov 1, 2021

Entrada Therapeutics enters Nasdaq

The Merck & Co and Roche-backed Duchenne muscular dystrophy drug developer has gone public in an upsized IPO sized at approximately $182m.

Nov 1, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here